Biologicals and biological response modifiers: new approaches to cancer treatment.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000951:Antigens, Neoplasm / Q000276:immunology; D001688:Biological Products / Q000627:therapeutic use*; D006801:Humans; D007167:Immunotherapy; D007370:Interferon Type I / Q000627:therapeutic use; D007371:Interferon-gamma / Q000627:therapeutic use; D007376:Interleukin-2; D008222:Lymphokines / Q000627:therapeutic use; D009369:Neoplasms / Q000628:therapy*; D013947:Thymosin / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; D001688:Biological Products; D007370:Interferon Type I; D007376:Interleukin-2; D008222:Lymphokines; D013947:Thymosin; D007371:Interferon-gamma